유럽의 생명과학 툴 및 시약 시장

The European market for life science tools and reagents and COVID-19 diagnostics products was valued at $14.7 billion in 2023. The market is expected to grow from $13.0 billion in 2024 to $15.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 3.4% from 2024 through 2029.

The European market for life science tools and reagents is expected to grow from $12.5 billion in 2024 to $15.3 billion by the end of 2029, at a CAGR of 4.2% from 2024 through 2029.

The European market for life science COVID-19 diagnostics products is expected to decline from $479.6 million in 2024 to $29.4 million by the end of 2029, at a negative CAGR of 42.8% from 2024 through 2029.

Report Scope

This report provides a comprehensive analysis of the European market for life science tools and reagents, including the leading companies, their revenues, product portfolios and recent activities. It looks at the competitive landscape, trends and market dynamics, such as drivers, restraints and opportunities. It also analyzes the current and future markets. The reagents studied are antibodies, enzyme-linked immunosorbent assay (ELISA) kits, protein reagents and probes. The life science tools included are hybridization systems, PCR, Western blotting instruments and ELISA instruments. The countries whose markets are analyzed are Germany, France, the U.K., Italy, Spain, Switzerland and the Rest of Europe. Markets are also analyzed by application.

Report Includes

• 33 data tables and 54 additional tables
• An analysis of the European market for life science tools and reagents, including COVID-19 diagnostics products
• Analyses of the market trends, with historic market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
• Estimates of the market size and revenue forecasts for the market for life science tools and reagents, with market share analysis by product, application, and country
• Discussions of the market dynamics, opportunities and challenges, as well as emerging technologies
• Overview of the sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG scores, and consumer attitudes
• Competitive intelligence, including companies' market shares, recent M&A activity and venture funding
• Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher Corp., Merck KGaA, Qiagen and Roche

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Product Development in Life Science

Chapter 3 Market Dynamics

• Global Market Dynamics
• Market Drivers
• Increasing Investments in R&D
• Increasing Prevalence of Chronic Diseases
• Increasing Demand for Various Diagnostics Pathways and In Vitro Diagnostics
• Growth in Genomic and Biomarker Research
• Increasing Demand for Personalized Medicine
• Technological Advances
• Market Restraints
• End of COVID-19 Pandemic
• High Cost of Instruments
• Lack of Skilled Personnels
• Market Challenges
• Regulatory Hurdles
• Market Opportunities
• Positive Impact from Some Revisions in Pharmaceutical Legislation
• New Technologies

Chapter 4 Emerging Technologies and Developments

• Overview
• Next-Generation Therapeutics
• Next-Generation Diagnostics
• Digitalization
• AI and Machine Learning
• Internet of Things (IoT)
• Robots in Life Science Labs

Chapter 5 Market Segmentation Analysis

• Overview
• Segmentation Breakdown
• European Market for Life Science Tools and Diagnostics, by Product Type
• COVID-19 Diagnostic Tests Market
• Market for Life Science Tools and Reagents
• European Market for Life Science Tools and Diagnostics, by Application
• Genomics
• Proteomics
• Cell Biology, Antibodies and Recombinant Proteins
• Stem Cells Research
• Imaging Tools and Techniques
• Animal Models
• Epigenetics
• Metabolomics
• Other Applications
• Europe
• United Kingdom
• Germany
• France
• Switzerland
• Spain
• Italy
• Rest of Europe

Chapter 6 Competitive Intelligence

• PCR Technologies and Reagents
• Antibodies
• ELISA Instruments
• ELISA Kits and Assays
• Life Science Kits and Assays
• COVID-19 Diagnostics
• Strategic Initiatives
• Recent Product Introductions in the Market

Chapter 7 Sustainability in Life Science Tools and Reagents in the European Market: An ESG Perspective

• Introduction to ESG
• ESG Practices in the Industry
• Status of ESG in the Industry
• Concluding Remarks from BCC

Chapter 8 Appendix

• Methodology
• Acronyms
• Sources
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• ALTONA DIAGNOSTICS GMBH
• ANALYTIK JENA GMBH+CO. KG
• BD
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• REVVITY INC.
• THERMO FISHER SCIENTIFIC INC.